BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11874453)

  • 1. Study of substrate specificity of human aromatase by site directed mutagenesis.
    Auvray P; Nativelle C; Bureau R; Dallemagne P; Séralini GE; Sourdaine P
    Eur J Biochem; 2002 Mar; 269(5):1393-405. PubMed ID: 11874453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active site acidic residues and structural analysis of modelled human aromatase: a potential drug target for breast cancer.
    Murthy JN; Nagaraju M; Sastry GM; Rao AR; Sastry GN
    J Comput Aided Mol Des; 2005 Dec; 19(12):857-70. PubMed ID: 16741831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding features of steroidal and nonsteroidal inhibitors.
    Hong Y; Rashid R; Chen S
    Steroids; 2011 Jul; 76(8):802-6. PubMed ID: 21420422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function relationships of human aromatase cytochrome P-450 using molecular modeling and site-directed mutagenesis.
    Graham-Lorence S; Khalil MW; Lorence MC; Mendelson CR; Simpson ER
    J Biol Chem; 1991 Jun; 266(18):11939-46. PubMed ID: 2050688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis for the aromatization reaction and exemestane-mediated irreversible inhibition of human aromatase.
    Hong Y; Yu B; Sherman M; Yuan YC; Zhou D; Chen S
    Mol Endocrinol; 2007 Feb; 21(2):401-14. PubMed ID: 17095574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-function studies of human aromatase by site-directed mutagenesis: kinetic properties of mutants Pro-308----Phe, Tyr-361----Phe, Tyr-361----Leu, and Phe-406----Arg.
    Zhou DJ; Pompon D; Chen SA
    Proc Natl Acad Sci U S A; 1991 Jan; 88(2):410-4. PubMed ID: 1988941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatase inhibitors: past, present and future.
    Séralini G; Moslemi S
    Mol Cell Endocrinol; 2001 Jun; 178(1-2):117-31. PubMed ID: 11403901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone complex and non-steroidal ligands of human aromatase.
    Ghosh D; Egbuta C; Lo J
    J Steroid Biochem Mol Biol; 2018 Jul; 181():11-19. PubMed ID: 29476820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A three-dimensional model of CYP19 aromatase for structure-based drug design.
    Karkola S; Höltje HD; Wähälä K
    J Steroid Biochem Mol Biol; 2007; 105(1-5):63-70. PubMed ID: 17583493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for androgen specificity and oestrogen synthesis in human aromatase.
    Ghosh D; Griswold J; Erman M; Pangborn W
    Nature; 2009 Jan; 457(7226):219-23. PubMed ID: 19129847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional domains of human aromatase cytochrome P450 characterized by linear alignment and site-directed mutagenesis.
    Amarneh B; Corbin CJ; Peterson JA; Simpson ER; Graham-Lorence S
    Mol Endocrinol; 1993 Dec; 7(12):1617-24. PubMed ID: 8145767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of molecular probes to study regulation of aromatase cytochrome P-450.
    Mendelson CR; Means GD; Mahendroo MS; Corbin CJ; Steinkampf MP; Graham-Lorence S; Simpson ER
    Biol Reprod; 1990 Jan; 42(1):1-10. PubMed ID: 1690030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-ray structure of human aromatase reveals an androgen-specific active site.
    Ghosh D; Griswold J; Erman M; Pangborn W
    J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):197-202. PubMed ID: 19808095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A site-directed mutagenesis study of human placental aromatase.
    Zhou DJ; Korzekwa KR; Poulos T; Chen SA
    J Biol Chem; 1992 Jan; 267(2):762-8. PubMed ID: 1730667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-function studies of human aromatase.
    Chen S; Zhou D; Swiderek KM; Kadohama N; Osawa Y; Hall PF
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):347-56. PubMed ID: 8476748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the mechanism of aromatase cytochrome P450. A site-directed mutagenesis study.
    Kao YC; Korzekwa KR; Laughton CA; Chen S
    Eur J Biochem; 2001 Jan; 268(2):243-51. PubMed ID: 11168357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional domains of aromatase cytochrome P450 inferred from comparative analyses of amino acid sequences and substantiated by site-directed mutagenesis experiments.
    Chen S; Zhou D
    J Biol Chem; 1992 Nov; 267(31):22587-94. PubMed ID: 1429608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis for the interaction of four different classes of substrates and inhibitors with human aromatase.
    Hong Y; Cho M; Yuan YC; Chen S
    Biochem Pharmacol; 2008 Mar; 75(5):1161-9. PubMed ID: 18184606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring substrate binding and discrimination in fructose1, 6-bisphosphate and tagatose 1,6-bisphosphate aldolases.
    Zgiby SM; Thomson GJ; Qamar S; Berry A
    Eur J Biochem; 2000 Mar; 267(6):1858-68. PubMed ID: 10712619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for the functional roles of critical residues in human cytochrome p450 aromatase.
    Lo J; Di Nardo G; Griswold J; Egbuta C; Jiang W; Gilardi G; Ghosh D
    Biochemistry; 2013 Aug; 52(34):5821-9. PubMed ID: 23899247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.